Recent advances in the synthesis of nanomaterials with diagnostic and therapeutic
capabilities have been rapidly reshaping the landscape of precision medicine. Impressive …

Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic
diseases in the 21st century, with a high mortality rate. This review summarizes the various …

Pseudomonas aeruginosa is the leading nosocomial and community-acquired pathogen
causing a plethora of acute and chronic infections. The Centers for Disease Control and …

Breast cancer is the most frequently happening cancer and the most typical cancer death
among females. Despite the crucial progress in breast cancer therapy by using …

Nanotechnology is envisaged to provide a dynamic approach to treat blocking of the
coronary arteries that occurs due to resistance to the normal blood flow to the heart …

Few therapies can reverse the proangiogenic activity of senescent mesenchymal
stromal/stem cells (MSCs). In this study, we investigated the effects of rapamycin on the …

Vascular-targeted carriers (VTCs) have the potential to localize therapeutics and imaging
agents to inflamed, diseased sites. Poly (lactic-co-glycolic acid)(PLGA) is a negatively …

The storied history of controlled the release systems has evolved over time; from degradable
drug-loaded sutures to monolithic zero-ordered release devices and nano-sized drug …

Vascular pathologies, such as myocardial infarction, stroke, and pulmonary embolism, are
major causes of morbidities and mortalities in the US and globally. A primary event in such …

Vascular-targeted drug delivery requires the successful localization and adhesion of drug
carriers to diseased sites via biomarkers, such as inflammation. Poly (lactic-co-glycolic …